Patient experience consulting for pharmaceutical companies
Placing the patient at the center of healthcare strategies: from therapy design to accompaniment throughout the care journey.
patients impacted
ecosystem collaborations
Who is it for? Pharmaceutical companies and medtechs looking to improve the engagement and experience of both patients and healthcare professionals, by placing the patient at the center of their therapies, services, and care pathways.
The Challenge
Patient experience is no longer a peripheral topic in healthcare strategy: it has become an evaluation criterion for therapies, a requirement from health authorities, and a differentiating factor for pharmaceutical companies and care providers alike. The HAS now integrates patient-reported outcomes (PROs) into its evaluations. Patient associations influence research protocols. And patients themselves - better informed and more connected - have growing expectations of their care.
Yet many organizations still approach patient experience as a communications or satisfaction exercise, rather than as a lever for transforming care.
Our Approach
We help healthcare stakeholders build patient-centered approaches that deliver concrete results - for patients and for organizations.
Patient research and co-design. We conduct qualitative studies and co-design processes with patients and associations to understand real needs, friction points in the care pathway, and unmet expectations. These insights feed directly into therapy development, service design, and the creation of support tools.
Patient support programs. We design and deploy therapeutic education (ETP), adherence, and psychosocial support programs in collaboration with medical teams and associations. These programs improve treatment adherence and reduce avoidable hospitalizations.
Integrating patient-generated data. Patient-reported data (PROs, ePROs, data from health apps) is an increasingly valuable source of information for medical teams, regulatory authorities, and payers. We structure their collection, analysis, and use in HTA submissions.
Our Results
Our 90+ collaborations with ecosystem partners - patient associations, digital health startups, hospital teams - have enabled us to co-develop solutions that genuinely improve patients' daily lives. More than 80,000 patients have benefited from the programs and solutions deployed through our engagements.
Frequently asked questions
Because it now drives therapy evaluation, treatment adherence, and differentiation. The HAS integrates patient-reported outcomes (PROs) into its evaluations, patient associations influence research protocols, and better-informed patients have growing expectations. Patient experience is no longer a communications topic: it is a lever for transforming care and perceived value.
By combining three levers: research and co-design with patients and associations to understand real needs, support programs (therapeutic education, adherence, psychosocial support) deployed with medical teams, and hybrid engagement models that complement healthcare professional interactions with personalized digital pathways.
These are data collected directly from patients (PROs, ePROs, health apps) about their condition, experience, and quality of life. They are an increasingly valuable source of information for medical teams, regulatory authorities, and payers. We structure their collection, analysis, and use, notably in HTA submissions.
